Literature DB >> 24898979

MiR-5000-3p, miR-5009-3P and miR-552: potential microRNA biomarkers of side population cells in colon cancer.

Zhong-Sheng Xia1, Lin Wang2, Tao Yu1, Wa Zhong1, Guo-Da Lian1, Di Wu1, Hui-Min Zhou1, Guang-Cheng Chen1.   

Abstract

Colon cancer is one of the most common cancers in the world. Multidrug resistance is related to poor prognosis of advanced colon cancer. The side population plays an important role in multiple drug resistance (MDR) of colon cancer. MicroRNA biomarkers of the side population of colon cancer is still unknown. In the present study, we aimed to explore miRNA markers of side population (SP) cells of colon cancer. The side population was sorted by flow cytometry. Cell viability was measured using an MTT assay. MicroRNA profiling analysis was performed to compare microRNA expression levels in the SP cells of colon cancer with levels in the non-SP cells of colon cancer. RT-PCR was applied to verify the result obtained from the microRNA profiling analysis. miR-5000-3p, miR-5009-3P and miR-552 were all found to be upregulated in SP cells of the colon cancer cell lines HCT-15, HT-29 and LoVo. RT-PCR confirmed the result from the microRNA profiling analysis. This implied that miR-5000-3p, miR-5009-3P and miR-552 may be potential microRNA biomarkers of the side population in colon cancer, which may provide new specific targets of the side population for the reversal of MDR of colon cancer.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24898979     DOI: 10.3892/or.2014.3232

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  10 in total

1.  MicroRNA-552 promotes tumor cell proliferation and migration by directly targeting DACH1 via the Wnt/β-catenin signaling pathway in colorectal cancer.

Authors:  Jia Cao; Xiu-Rui Yan; Ting Liu; Xue-Bo Han; Jing-Jing Yu; Shi-Hai Liu; Li-Bin Wang
Journal:  Oncol Lett       Date:  2017-07-18       Impact factor: 2.967

2.  Study on miRNAs in Pan-Cancer of the Digestive Tract Based on the Illumina HiSeq System Data Sequencing.

Authors:  Chun-Hui Lai; Xu-Zhi Liang; Xiu-Yun Liang; Sheng-Jun Ma; Jun-Guo Li; Ming-Fang Shi; Xu Zhu; Hui-Hua Lan; Jiang-Hui Zeng
Journal:  Biomed Res Int       Date:  2019-10-15       Impact factor: 3.411

3.  MicroRNAs Expression Patterns Predict Tumor Mutational Burden in Colorectal Cancer.

Authors:  Jiahao Huang; Haizhou Liu; Yang Zhao; Tao Luo; Jungang Liu; Junjie Liu; Xiaoyan Pan; Weizhong Tang
Journal:  Front Oncol       Date:  2021-02-09       Impact factor: 6.244

4.  Identification of Functional Genes in Pterygium Based on Bioinformatics Analysis.

Authors:  Yuting Xu; Chen Qiao; Siying He; Chen Lu; Shiqi Dong; Xiying Wu; Ming Yan; Fang Zheng
Journal:  Biomed Res Int       Date:  2020-11-20       Impact factor: 3.411

5.  MicroRNA-552 expression in colorectal cancer and its clinicopathological significance.

Authors:  Joon Im; Soo Kyung Nam; Hye Seung Lee
Journal:  J Pathol Transl Med       Date:  2021-02-19

6.  Linc00261 Inhibited High-Grade Serous Ovarian Cancer Progression through miR-552-ATG10-EMT Axis.

Authors:  Lin Wang; Hongcai Wang; Jiuwei Chen
Journal:  Comput Math Methods Med       Date:  2022-04-12       Impact factor: 2.809

7.  miR-5000-3p confers oxaliplatin resistance by targeting ubiquitin-specific peptidase 49 in colorectal cancer.

Authors:  Yan-Yan Zhuang; Wa Zhong; Zhong-Sheng Xia; Shu-Zhen Lin; Man Chung Chan; Ke Jiang; Wen-Fei Li; Xin-Yi Xu
Journal:  Cell Death Discov       Date:  2021-06-01

8.  MicroRNA-552 enhances metastatic capacity of colorectal cancer cells by targeting a disintegrin and metalloprotease 28.

Authors:  Jian Wang; Hai Li; Yong Wang; Libin Wang; Xiurui Yan; Dong Zhang; Xiaoqiang Ma; Yong Du; Xiaoming Liu; Yinxue Yang
Journal:  Oncotarget       Date:  2016-10-25

9.  MicroRNA-552 promotes hepatocellular carcinoma progression by downregulating WIF1.

Authors:  Chao Li; Zi Wang; Shuangjiang Chen; Jingyao Zhang; Kai Qu; Chang Liu
Journal:  Int J Mol Med       Date:  2018-09-17       Impact factor: 4.101

10.  MiR-552 promotes the proliferation, migration and EMT of hepatocellular carcinoma cells by inhibiting AJAP1 expression.

Authors:  Weiqing Qu; Xinyuan Wen; Keli Su; Wei Gou
Journal:  J Cell Mol Med       Date:  2018-12-30       Impact factor: 5.310

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.